Plasma Natriuretic Peptides for Community Screening for Left Ventricular Hypertrophy and Systolic Dysfunction

Ramachandran S. Vasan; Emelia Benjamin; Martin G. Larson; Eric Leip; Thomas J. Wang; Peter W.F. Wilson; Daniel Levy

doi:10.1001/jama.288.10.1252

Abstract

1 min read

In our large community-based sample, the performance of BNP and NT-ANP for detection of elevated LV mass and LVSD was suboptimal, suggesting limited usefulness of natriuretic peptides as mass screening tools.

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2013

Association of Novel Biomarkers of Cardiovascular Stress With Left Ventricular Hypertrophy and Dysfunction: Implications for Screening

Vanessa Xanthakis, Martin G. Larson, Kai C. Wollert, Jayashri Aragam, Susan Cheng, Jennifer E. Ho, Erin Coglianese, Daniel Levy, Wilson S. Colucci, G. Michael Felker, Emelia Benjamin, James L. Januzzi, Thomas J. Wang, Ramachandran S. Vasan

Article2003

The Epidemiology of Asymptomatic Left Ventricular Systolic Dysfunction: Implications for Screening

Thomas J. Wang, Daniel Levy, Emelia Benjamin, Ramachandran S. Vasan

Article2003

Plasma Brain Natriuretic Peptide Levels and Blood Pressure Tracking in the Framingham Heart Study

M. Freitag, Martin G. Larson, Daniel Levy, Emelia Benjamin, Thomas J. Wang, Eric Leip, Peter W.F. Wilson, Ramachandran S. Vasan

Article2010

Gender Dimorphic Associations between N-Terminal Pro-Brain Natriuretic Peptide, Body Mass Index and Blood Pressure in Children and Adolescents

Panagiota Pervanidou, Athanassios Akalestos, Sophia Sakka, Christina Kanaka‐Gantenbein, Ioannis Papassotiriou, George Chrousos

Article2010

Relations of Serum Phosphorus Levels to Echocardiographic Left Ventricular Mass and Incidence of Heart Failure in the Community

Ravi Dhingra, Philimon Gona, Emelia Benjamin, Thomas J. Wang, Jayashri Aragam, Ralph B. D’Agostino, William B. Kannel, Ramachandran S. Vasan